Advanced search    

Search: authors:"G. Sunder-Plassmann"

6 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Thrombotische Mikroangiopathien

Die thrombotische Mikroangiopathie (TMA) ist klinisch durch eine mechanische Hämolyse, eine geringradig bis stark ausgeprägte Thrombopenie und ein akutes Nierenversagen charakterisiert. Differenzialdiagnostisch kommen das atypische hämolytisch-urämische Syndrom (aHUS), die thrombotisch-thrombozytopenische Purpura (TTP), das Shiga-Toxin-assoziierte HUS (STEC-HUS, früher typisches ...

Safety of intravenous injection of iron saccharate in haemodialysis patients

Background. The most frequent i.v. iron preparations used for haemodialysis patients are iron dextran, iron gluconate and iron saccharate. Possible side effects include anaphylactic reactions due to preformed antibodies to dextran or vascular reactions due to unbound iron during treatment with iron gluconate or iron saccharate. Methods. Four dosage regimens of i.v. iron saccharate ...

Alternative puncture site for implantable permanent haemodialysis catheters

Background. Vascular access represents a major problem in long-term haemodialysis patients. In patients without patent internal arteriovenous fistula, the implantation of cuffed catheters to provide a temporary or permanent central venous access is often necessary. Catheterization of the subclavian vein should be avoided because of the high risk of stenosis or thrombosis. The ...

Disturbed latex immunoassays for C-reactive protein and ferritin in a renal transplant patient due to polyclonal IgM hypergammaglobulinaemia.

BACKGROUND: C-reactive protein (CRP) and ferritin serum levels represent routine laboratory parameters in the monitoring of renal failure patients. Analysis of CRP, ferritin and other serum proteins can be performed using latex-enhanced or non-latex-enhanced immunoassays. We report on a renal transplant patient with polyclonal IgM hypergammaglobulinaemia having markedly elevated ...

Resistance to activated protein C (APC): mutation at ARG506 of coagulation factor V and vascular access thrombosis in haemodialysis patients

M. Fodinger C. Mannhalter . Pabinger D. Koizar C. Rintelen W. H. Horl G. Sunder-Plassmann Background. Vascular access thrombosis represents a serious problem in haemodialysis patients. Therefore

Epidemiology - CKD 5D II

Introduction and Aims: Adherence to treatment recommendations on diet, fluid and medication is important to maximize good clinical outcomes in Hemodialysis yet it remains suboptimal and not well-understood. This trial set out to examine the effect of the HED- SMART intervention, a four-session, group-delivered self-management intervention on treatment adherence indicators. Methods: ...